PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34428860-6	2022	The meta-analysis showed that roxadustat increased haemoglobin (Hb) level by 0.91 g/dL (95% confidence interval (CI): 0.47-1.34, P<0.05), transferrin level by 0.50 mg/dL (95% CI: 0.34-0.65, P<0.05), and total iron-binding capacity by 50.64 mug/dL (95% CI: 36.21-65.07, P<0.05) in CKD patients.	roxadustat	30-40	transferrin	Homo sapiens	138-149	
31340116-12	2019	As compared with epoetin alfa, roxadustat increased the transferrin level (difference, 0.43 g per liter; 95% CI, 0.32 to 0.53), maintained the serum iron level (difference, 25 mug per deciliter; 95% CI, 17 to 33), and attenuated decreases in the transferrin saturation (difference, 4.2 percentage points; 95% CI, 1.5 to 6.9).	roxadustat	31-41	transferrin	Homo sapiens	56-67	
31340116-12	2019	As compared with epoetin alfa, roxadustat increased the transferrin level (difference, 0.43 g per liter; 95% CI, 0.32 to 0.53), maintained the serum iron level (difference, 25 mug per deciliter; 95% CI, 17 to 33), and attenuated decreases in the transferrin saturation (difference, 4.2 percentage points; 95% CI, 1.5 to 6.9).	roxadustat	31-41	transferrin	Homo sapiens	246-257